NASDAQ:ITRM Shareholder Notice: Lawsuit Alleges Misleading Statements by Iterum Therapeutics Plc
An investor, who purchased shares of Iterum Therapeutics plc (NASDAQ:ITRM), filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by Iterum Therapeutics plc in connection with certain allegedly false and misleading statements made between November 30, 2020 and July 23, 2021.
View full press release